Sartorius Stedim Biotech delivered indispensable biopharma supplies
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
-
-
Oxford University launched world’s first COVID-19 government response tracker
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
-
Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response
On Mar. 25, 2020, Royal Philips announced that Children’s Hospital of Georgia has adopted Philips’ automated early detection…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Oxford University COVID-19 study showed that Wuhan travel restrictions prevented wider disease spread
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | HIV | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics | Vaccine
Life sciences companies commit to fight against COVID-19 pandemic with Bill & Melinda Gates Foundation
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
-
Vir Biotech proceeded with two clinical development candidates for COVID-19
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
-
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
-
CHF Solutions announced COVID-19 patients treated with Aquadex therapy for fluid management with Coronavirus treatment
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
-
Merck donated 300,000 masks to New Jersey for COVID-19 emergency response
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
-
Mylan waives US marketing exclusivity for Lopinavir/Ritonavir to ensure availability for COVID-19 patient needs
On Mar. 25, 2020, Mylan announced that, in its ongoing effort to support patients and public health needs in the…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 25, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
-
T2 Biosystems announced worldwide licensing agreement of COVID-19, novel Coronavirus assay
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
-
Partner Therapeutics announced initiation of clinical trial to evaluate Leukine in patients with COVID-19
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
-
New COVID-19 assay adapted to run on T2 Biosystems’ FDA-cleared T2Dx Instrument
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
-
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
-
Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
-
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
-
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor Co. announced that they had entered into a partnership in…
-
Bausch Health donated products and supplies in response to COVID-19 pandemic
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
-
FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
-
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, an international project aimed to enroll 500 COVID-19 patients to search for genetic mutations…
-
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Oxford University’s COVID-19 research received government funding
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
-
bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
-
Dynavax and Clover Biopharmaceuticals announced COVID-19 research collaboration
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announced a research…
-
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point of Care molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
-
Ology Bioservices, Inovio partnered to manufacture COVID-19 DNA vaccine with $11.9 million DoD grant
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
Windtree announced clinical study of lung injury treatment in COVID-19 patients with its KL4 surfactant therapy
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
